Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03202953
Other study ID # 4-2017-0400
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 4, 2017
Est. completion date January 24, 2018

Study information

Verified date May 2018
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the 1: 1 I: E ratio VCV and the autoflow VCV in patients undergoing robot assisted laparoscopic prostatectomy


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date January 24, 2018
Est. primary completion date January 24, 2018
Accepts healthy volunteers No
Gender Male
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

1. adult (20-80 years old)

2. patients undergoing robot assisted laparoscopic prostatectomy

Exclusion Criteria:

1. history of COPD

2. decreased heart function (EF <50%)

3. BMI>30

4. patients who cannot read the consent form (e.g., blind, foreigner)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ventilation strategy 1
In Group I, after trendelenburg position, patients will be applied 1:1 ratio VCV. Tidal volume : 8ml/kg, inspiration:expiration ratio = 1:1, FiO2 = 0.5, maintain end tidal CO2 around 40±5 mmHg. Positive end expiratory pressure will not used.
ventilation strategy 2
In group A, after trendelenburg position, patients will be applied autoflow VCV. - Tidal volume : 8ml/kg, inspiration:expiration ratio = 1:2, FiO2 = 0.5, maintain end tidal CO2 around 40±5 mmHg. Positive end expiratory pressure will not used.

Locations

Country Name City State
Korea, Republic of Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary PaO2 PaO2 analyzed by arterial blood gas analysis 30 minutes after trendelenburg position
Secondary PaO2 10 minutes after induction (T1), 30 minutes after trendelenburg position (T2), 60 minutes after trendelenburg position (T3), 10 minutes after supine position (T4)
Secondary End tidal CO2 10 minutes after induction (T1), 30 minutes after trendelenburg position (T2), 60 minutes after trendelenburg position (T3), 10 minutes after supine position (T4)
Secondary peak airway pressure 10 minutes after induction (T1), 30 minutes after trendelenburg position (T2), 60 minutes after trendelenburg position (T3), 10 minutes after supine position (T4)
Secondary blood pressure 10 minutes after induction (T1), 30 minutes after trendelenburg position (T2), 60 minutes after trendelenburg position (T3), 10 minutes after supine position (T4)
Secondary Arterial blood gas analysis pH, SaO2, Base excess 10 minutes after induction (T1), 30 minutes after trendelenburg position (T2), 60 minutes after trendelenburg position (T3), 10 minutes after supine position (T4)